InsidersTradesSigma
Total declarations
Companies
▲ Purchases (16 ops.)
▼ Sales (6 ops.)
Insider track record
OtherDisclosed buys
16
Disclosed sells
6
T+90 hit rate
11%
T+90 mean return
-21.8%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by STEPHENSON BRIAN C, Autre. Officer active across 2 companies, notably BridgeBio Pharma, Inc.. Cumulatively, 44 filings have been published. Split: 16 buys · 6 sells. Total volume traded: €3.4m. History available since 5 January 2023. The latest transaction was filed on 25 February 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations44 total
2,891 sharesCommon StockSEC:0001780030-26-000005:0
Ideal exit: 21 Mar 2027 (T+270)
3,000 sharesCommon StockSEC:0001780030-26-000005:1
Ideal exit: 21 Mar 2027 (T+270)
3,400 sharesCommon StockSEC:0001780030-26-000005:2
Ideal exit: 21 Mar 2027 (T+270)
100 sharesCommon StockSEC:0001780030-26-000005:3
Ideal exit: 21 Mar 2027 (T+270)
580 sharesCommon StockSEC:0001780030-26-000005:4
Ideal exit: 23 Mar 2027 (T+270)
4,212 sharesCommon StockSEC:0001780030-26-000005:5
Ideal exit: 23 Mar 2027 (T+270)
1,358 sharesCommon StockSEC:0001780030-26-000005:6
Ideal exit: 23 Mar 2027 (T+270)
100 sharesCommon StockSEC:0001780030-26-000005:7
Ideal exit: 23 Mar 2027 (T+270)
1,797 sharesCommon StockSEC:0001780030-26-000004:0
Ideal exit: 19 Mar 2027 (T+270)
1,118 sharesCommon StockSEC:0001780030-26-000004:1
Ideal exit: 19 Mar 2027 (T+270)
1,583 sharesCommon StockSEC:0001780030-26-000004:2
Ideal exit: 19 Mar 2027 (T+270)
3,329 sharesCommon StockSEC:0001780030-26-000004:3
Ideal exit: 19 Mar 2027 (T+270)
356 sharesCommon StockSEC:0001780030-26-000004:4
Ideal exit: 19 Mar 2027 (T+270)
6,836 sharesCommon StockSEC:0001780030-26-000004:5
Ideal exit: 20 Mar 2027 (T+270)
1,969 sharesCommon StockSEC:0001780030-26-000004:6
Ideal exit: 20 Mar 2027 (T+270)
425 sharesCommon StockSEC:0001780030-26-000004:7
Ideal exit: 20 Mar 2027 (T+270)
8,500 shares@ US$17.003.0% of flowCommon StockSEC:0000950170-25-029262:0
25,798 sharesCommon StockSEC:0000950170-25-023630:0
68,000 shares@ US$17.0023.8% of flowCommon StockSEC:0000950170-25-011242:0
4,156 shares@ US$22.41021.9% of flowCommon StockSEC:0000950170-24-129452:0
25,799 sharesCommon StockSEC:0000950170-24-128888:0
25,797 sharesCommon StockSEC:0000950170-24-099269:0
27,507 sharesCommon StockSEC:0000950170-24-061638:0
44,996 sharesCommon StockSEC:0000950170-24-017895:0
44,996 sharesCommon StockSEC:0001209191-23-056015:0
25 of 44 declarations
About STEPHENSON BRIAN C
Brian C. Stephenson is involved in various activities at BridgeBio Pharma, Inc. His role includes strategic contributions to the company's leadership. Brian C. Stephenson is committed to supporting innovation and growth within the organization.
